FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national ...

The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters ...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply ...

Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Factor XIIa inhibitor Andembry (garadacimab) has been cleared in the US for use in patients aged 12 and over with HAE, which ...

The Information Commissioner's Office (ICO) has levied a £2.31 million ($3.13 million) penalty on the Californian company in connection with a cyberattack in 2023 that resulted in the personal ...